Patent Approval Reinforces Nexalin’s Leadership in Non-Invasive Brain Stimulation for Addiction Treatment HOUSTON, TX, April 14, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) ...

HOUSTON, TX, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (NXL) (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) the leader in Deep Intracranial Frequency Stimulation (DIFS™) of the ...

(LANSING, MICH) The Michigan Department of Insurance and Financial Services (DIFS) announced that more Michiganders are appealing health insurance claim denials under the Patient's Right to ...

Michigan’s Department of Insurance and Financial Services (DIFS) requires insurance producers (individual agents/brokers and business agencies, collectively, “Insurance Producers”) to provide notice ...

(RTTNews) - Nexalin Technology, Inc. (NXL) has highlighted a growing body of peer-reviewed neuroimaging research that reinforces its Deep Intracranial Frequency Stimulation (DIFS) technology as a ...

HOUSTON, TX, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (NXL) (the “Company” or “Nexalin”), the leader in non-invasive Deep Intracranial Frequency Stimulation (DIFS™) of the brain, ...

Patent Strengthens Nexalin’s Intellectual Property Portfolio and Highlights the Potential of DIFS™ Technology in Addressing Substance Use Disorders, Including Opioids, Alcohol, Cocaine and ...

Nexalin Technology (NXL) announces the publication of a landmark study in the Journal of Affective Disorders demonstrating the potential efficacy of its proprietary DIFS technology. The research ...

On January 14, Michigan’s Department of Insurance and Financial Services (DIFS) issued a bulletin reminding all financial service providers regulated by DIFS that decisions and actions made using ...

The paper trail for consumer complaints against auto insurance companies in Michigan is challenging to track. Under state law, specific complaints filed against insurers with the Michigan Department ...